This mutationmight induce OI by impairing the ability of PDI to combine with type I procollagenand leading to disorder of the type I collagen triple helix formation.Bisphosphonates were effective in this extremely rare type OI. The gene discussed is P4HB; the disease is osteogenesis imperfecta.